The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary endpoint in amyotrophic lateral sclerosis (ALS), but its findings shed ...

Low-density lipoproteins were above clinically acceptable levels at 3.77 mmol/l. The participant had an elevated level of alanine transaminase indicative of reduction in liver function. In addition, ...

Blood tests to measure liver levels, including aspartate transaminase (AST) and alanine aminotransferase (ALT), were elevated in at least one of these people. Once curcumin was stopped, AST and ALT ...

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2024 and provided a corporate ...

While this is considered clinically significant, it is unknown how often ceftriaxone induces such substantial increases in hepatic transaminase levels. Our patient had severe meningitis ...

19 Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, and 2nd Department of Medicine, Hietzing Hospital, Vienna, Austria 20 Department of Rheumatology, Seoul National ...